Navigation Links
Tekni-Plex, Inc. Announces Expiration Of Change Of Control Offer To Purchase Its 9.750% Senior Secured Notes Due 2019
Date:1/13/2014

KING OF PRUSSIA, Pa., Jan. 13, 2014 /PRNewswire/ -- Tekni-Plex, Inc. (the "Company") today announced the expiration of its previously announced offer to purchase (the "Offer") any and all of its outstanding 9.750% senior secured notes due 2019 (the "Notes"). The Offer was made solely to fulfill the Company's obligations under the indenture governing the Notes following the consummation on December 13, 2013 of the previously announced merger (the "Merger") with an affiliate of American Securities LLC, which resulted in a "Change of Control" giving the holders of the Notes the right to require the Company to purchase all or a portion of such holders' Notes at a purchase price of 101% of the principal amount thereof, plus any accrued and unpaid interest up to, but not including, the date of purchase.

The Offer was commenced on December 13, 2013 and expired at 5:00 P.M., New York City Time, on Friday, January 10, 2014 (the "Expiration Date"). As of the Expiration Date, $74,000 in aggregate principal amount of the Notes (representing approximately 0.02% of the outstanding Notes) had been delivered for repurchase pursuant to the Offer.  Payment for the tendered notes will occur on January 15, 2014.

This press release shall not constitute an offer to sell or a solicitation of an offer to purchase the Notes or any other securities.

About Tekni-Plex, Inc.

Tekni-Plex, Inc. is a global manufacturer of technically-sophisticated products and components engineered to meet critical customer needs in niche applications. The Company operates in three segments: Healthcare, Specialty Packaging and Food Packaging. Tekni-Plex's primary products include closure liners, medical tubing, high-barrier pharmaceutical films, medical compounds, dispensing components and thermoformed containers.   The Company is headquartered in King of Prussia, PA and operates 25 manufacturing facilities across nine countries worldwide to meet the needs of its global customers. For more information on the capabilities of Tekni-Plex, visit www.tekni-plex.com or call the Company at (484) 690-1520.

Contact:
Graham Sayers
Executive Vice President &
Chief Financial Officer
Graham.Sayers@Tekni-Plex.com


'/>"/>
SOURCE Tekni-Plex, Inc.
Copyright©2012 PR Newswire.
All rights reserved

Related medicine technology :

1. Tekni-Plex, Inc. To Hold Teleconference To Discuss Financial Results For Fiscal Year 2013 On September 12, 2013
2. Debiopharm Group Announces Completion of Recruitment for Phase III Clinical Study with Triptorelin 22.5 mg in Central Precocious Puberty
3. Adaptive Announces a Biomarker Discovery Agreement with Johnson & Johnson Innovation
4. Medical Tracking Solutions, Inc. announces new client NovaBone Products, LLC
5. Volcano Corporation Announces Preliminary Fourth Quarter 2013 Revenues; Year-Over-Year Annual Revenues Increase Eight Percent On A Constant Currency Basis
6. Millennium Laboratories Announces Strategic Acquisition of RxAnte
7. Jazz Pharmaceuticals Announces Acquisition From Aerial Biopharma Of Rights To A Late Stage Investigational Compound For Excessive Daytime Sleepiness
8. Avanir Pharmaceuticals Pre-announces Preliminary Fiscal 2014 First Quarter Financial Information
9. Seres Health Announces Interim Clinical Data for SER-109 in Recurrent C. difficile
10. Concordia Healthcare Corp. announces FDA agreement on Special Protocol Assessment for Phase 3 Clinical trial on new therapy to treat perihilar cholangiocarcinoma
11. Mindray Announces Preliminary 2013 Operating Results and 2014 Net Revenue Guidance
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/20/2017)... 20, 2017 Research and Markets ... Pipeline and Market Prospects: Addressing Production Complexities Through Risk ... offering. ... "Global Biosimilar Pipeline and Market Prospects: Overcoming Production Complexities ... in-depth assessment of the current trends in the global ...
(Date:4/20/2017)... --  ZappRx, Inc ., a digital health company focused on ... it closed $25 million in Series B funding led by ... Seattle that is part of a ... B round included participation from SR One , who ... (formerly Google Ventures). As part of the financing, ...
(Date:4/20/2017)... 20, 2017 NeuroVive Pharmaceutical AB (Nasdaq ... positive preclinical results demonstrating anti-fibrotic effects with ... steatohepatitis (NASH), in an additional well-validated experimental ... has previously shown similar anti-fibrotic effects in ... scientists present novel data demonstrating anti-fibrotic effects ...
Breaking Medicine Technology:
(Date:4/28/2017)... ... April 28, 2017 , ... From April ... of Urgent Care Medicine will host industry leaders for the annual spring Convention ... those in the industry adapt to the issues currently affecting urgent care and ...
(Date:4/28/2017)... ... April 28, 2017 , ... People are starting to ... “Wearing a hearing aid doesn’t have the stigma it had when great-grandpa wore his ... of Greater Boston, in a NALA North American Speaker Series (NASS) segment. ...
(Date:4/28/2017)... ... ... Hawkins, Pastor and Overseer at The House of Yahweh in Abilene, Texas, has published a ... does not. Yisrayl says with so many titles and names for the Creator, it’s ... with a little Scripture, backed with a lot of research, the truth is undeniable. ...
(Date:4/28/2017)... , ... April 28, 2017 , ... ... for the North East region. Côté has 20+ years of experience within the ... Phytomer, Côté worked with an array of high-end cosmetic brands, retail brands and ...
(Date:4/28/2017)... ... April 28, 2017 , ... ... advanced nutraceutical supplements, through its Nova Skin Sciences division, recently announced the launch ... a moisturizer with the power of an anti-aging concentrate. , Anogeissus ...
Breaking Medicine News(10 mins):